Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2016-09-27Clinical Trial Update: Genetic Influence on Statin Pharmacodynamics
A clinical trial investigating genetic influence on statin pharmacodynamics was withdrawn from the registry.
-
CLINICAL_TRIALS trial_result · 2016-09-21Clinical Trial Update: PERIODONTAL DISEASE AND HYPERLIPIDEMIA
A completed clinical study from Ondokuz Mayıs University evaluated the relationship between periodontal disease (gingivitis and periodontiti…
-
FDA approval · 2016-09-07FDA Approved: FENOFIBRIC ACID — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's fenofibric acid under an original ANDA for treatment of lipid disorders including …
-
CLINICAL_TRIALS trial_result · 2016-09-05Clinical Trial Update: Randomized Comparative Efficacy and Safety Study of Intermittent Simvastatin and Fenofibrate in Hemodialysis [Phase 4]
A Phase 4 randomized study compares intermittent simvastatin and fenofibrate for efficacy and safety in patients undergoing hemodialysis.
-
CLINICAL_TRIALS trial_result · 2016-08-31Clinical Trial Update: Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody [Phase 3]
Phase 3 trial evaluating effects on lipoprotein metabolism from PCSK9 inhibition using a monoclonal antibody in primary hyperlipidemia and m…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-08-08Clinical Trial Update: Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia [Phase 2]
Phase 2 study evaluating ARI-3037MO to suppress LDL cholesterol in patients with hyperlipidemia; status is unknown.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [Phase 3]
Phase 3 ALLHAT trial update reporting completed results evaluating antihypertensive therapies (chlorthalidone, lisinopril, amlodipine, and d…
-
CLINICAL_TRIALS trial_result · 2016-07-21Clinical Trial Update: A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques [NA]
A clinical trial update evaluating the effect of Rosuvastatin on carotid atherosclerotic plaques using high-resolution MRI, sponsored by Cap…
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Glenmark Pharmaceutials Inc., USA)
FDA approves rosuvastatin calcium as an original generic application from Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTAIN CALCIUM — Original Application (Chartwell RX, LLC)
FDA approves ROSUVASTAIN CALCIUM as an original generic (ANDA) application for rosuvastatin calcium. The approval enables marketing of this …
-
FDA approval · 2016-07-19FDA Approved: ROSUVASTATIN CALCIUM — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original Abbreviated New Drug Application for rosuvastatin calcium from Rising Pharma Holdings, Inc.
-
FDA approval · 2016-07-12FDA Approved: FENOFIBRATE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' fenofibrate generic as an Original Application for the treatment of lipid disorders. The approval cover…
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Is There a Relationship Between Hyperlipidemia and Periodontitis?
A Marmara University–sponsored clinical trial completed a study exploring whether hyperlipidemia is related to periodontal disease (periodon…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine [Phase 1]
Phase 1 pharmacokinetic study evaluating potential drug interaction between rosuvastatin and the telmisartan/amlodipine combination.
-
FDA approval · 2016-06-23FDA Approved: FENOFIBRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original generic application for fenofibrate from Mylan Pharmaceuticals Inc., enabling the marketing of a fenofibrate produ…
-
FDA approval · 2016-06-17FDA Approved: GEMFIBROZIL — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals Limited's original ANDA for gemfibrozil, authorizing a generic version of the lipid-lowering drug.
-
CLINICAL_TRIALS research · 2016-06-07Clinical Trial Update: The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia [EARLY_Phase 1]
An early-phase 1 trial assessed the effects of Rhus coriaria L. on serum lipid levels in patients with hyperlipidemia; the study has complet…
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: DP-R212 Pharmacokinetic Study [Phase 1]
Phase 1 pharmacokinetic study of DP-R212 sponsored by Alvogen Korea. It targets hypertension and hyperlipidemia; current trial status is unk…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: The Effectiveness of Plant Stanols as Ester on Change in Blood Cholesterol Level [NA]
A completed clinical trial from Yonsei University evaluated the effect of plant stanol esters on changes in LDL-cholesterol levels.
-
FDA approval · 2016-05-19FDA Approved: ATORVASTATIN CALCIUM — Original Application (Cipla USA Inc.,)
The FDA approved Cipla USA Inc.'s atorvastatin calcium tablet as an Original Application, enabling a generic atorvastatin calcium product to…
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis [NA]
This terminated clinical trial evaluated the effects of the TNF-alpha antagonist etanercept in patients with psoriasis and metabolic syndrom…
-
CLINICAL_TRIALS trial_result · 2016-05-12Clinical Trial Update: Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy [Phase 3]
A Phase 3 trial evaluating Niaspan for dyslipidemia in patients with diabetic nephropathy was terminated. Results were posted in 2016.
-
CLINICAL_TRIALS other · 2016-05-12Clinical Trial Update: Can Cholesterol Lowering Drugs Influence Circulating Omega-3 Fatty Acid Levels [NA]
A completed clinical trial evaluated whether cholesterol-lowering drugs influence circulating omega-3 fatty acid levels. The study was spons…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: Cardiovascular Intervention Improvement Telemedicine Study [NA]
A completed cardiovascular telemedicine study by VA on hypertension and related conditions with results posted in 2016.
-
FDA approval · 2016-05-05FDA Approved: SIMVASTATIN — Supplemental Application (Biocon Pharma Inc,)
FDA approved Biocon Pharma Inc.'s supplemental application for simvastatin (ANDA 078034). This confirms an approved modification to the gene…